Description
FOR ANIMAL USE ONLY
BOVI-TECT PI
Reg. No. G3001 (Act 36/1947)
Namibia Reg. No. V02/24.4/786 [NS0]
INDICATIONS
The combination vaccine reduces the incidence of morbidity and mortality caused by undifferentiated bovine respiratory diseases (pasteurellosis) associated with M. (Pasteurella) haemolytica and BHV 1 (infectious bovine rhinotracheitis – IBR).
This vaccine is also recommended for inclusion in a vaccination programme for feedlot cattle at processing.
COMPOSITION
Mannheimia (Pasteurella) haemolytica biotype A serotype 1/17 cell-free supernatant leukotoxin vaccine for cattle, to be used in conjunction with modified live bovine herpes virus 1 (BHV 1), supplied in a smaller vial labeled Bovi-Tect PI IBR component.
For optimal use, consult your veterinarian.
